These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 17255548)

  • 41. Body temperature and response to thrombolytic therapy in acute ischaemic stroke.
    Millán M; Grau L; Castellanos M; Rodríguez-Yáñez M; Arenillas JF; Nombela F; Pérez de la Ossa N; López-Manzanares L; Serena J; Castillo J; Dávalos A
    Eur J Neurol; 2008 Dec; 15(12):1384-9. PubMed ID: 19049558
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous thrombolysis for acute ischemic stroke occurring during hospitalization for transient ischemic attack.
    Tsivgoulis G; Sharma VK; Mikulik R; Krogias C; Haršány M; Bavarsad Shahripour R; Athanasiadis D; Teoh HL; Piperidou C; Alexandrov AV
    Int J Stroke; 2014 Jun; 9(4):413-8. PubMed ID: 23981541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
    Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion.
    Alvarez-Sabín J; Molina CA; Ribó M; Arenillas JF; Montaner J; Huertas R; Santamarina E; Rubiera M
    Stroke; 2004 Nov; 35(11):2493-8. PubMed ID: 15472110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The presence of a right-to-left shunt is associated with dramatic improvement after thrombolytic therapy in patients with acute ischemic stroke.
    Kimura K; Iguchi Y; Shibazaki K; Terasawa Y; Aoki J; Matsumoto N
    Stroke; 2009 Jan; 40(1):303-5. PubMed ID: 18845803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tandem internal carotid artery/middle cerebral artery occlusion: an independent predictor of poor outcome after systemic thrombolysis.
    Rubiera M; Ribo M; Delgado-Mederos R; Santamarina E; Delgado P; Montaner J; Alvarez-Sabín J; Molina CA
    Stroke; 2006 Sep; 37(9):2301-5. PubMed ID: 16888266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Permeable Thrombi Are Associated With Higher Intravenous Recombinant Tissue-Type Plasminogen Activator Treatment Success in Patients With Acute Ischemic Stroke.
    Santos EM; Dankbaar JW; Treurniet KM; Horsch AD; Roos YB; Kappelle LJ; Niessen WJ; Majoie CB; Velthuis B; Marquering HA;
    Stroke; 2016 Aug; 47(8):2058-65. PubMed ID: 27338928
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial.
    Molina CA; Barreto AD; Tsivgoulis G; Sierzenski P; Malkoff MD; Rubiera M; Gonzales N; Mikulik R; Pate G; Ostrem J; Singleton W; Manvelian G; Unger EC; Grotta JC; Schellinger PD; Alexandrov AV
    Ann Neurol; 2009 Jul; 66(1):28-38. PubMed ID: 19670432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.
    Albers GW; Bates VE; Clark WM; Bell R; Verro P; Hamilton SA
    JAMA; 2000 Mar; 283(9):1145-50. PubMed ID: 10703776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of tissue-type plasminogen activator nonresponders according to location of vessel occlusion.
    Mendonça N; Rodriguez-Luna D; Rubiera M; Boned-Riera S; Ribo M; Pagola J; Piñeiro S; Meler P; Alvarez-Sabin J; Montaner J; Molina CA
    Stroke; 2012 Feb; 43(2):417-21. PubMed ID: 22135072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recanalization after intravenous thrombolysis: does a recanalization time window exist?
    Wunderlich MT; Goertler M; Postert T; Schmitt E; Seidel G; Gahn G; Samii C; Stolz E; ;
    Neurology; 2007 Apr; 68(17):1364-8. PubMed ID: 17452580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Smoking-thrombolysis paradox: recanalization and reperfusion rates after intravenous tissue plasminogen activator in smokers with ischemic stroke.
    Kufner A; Nolte CH; Galinovic I; Brunecker P; Kufner GM; Endres M; Fiebach JB; Ebinger M
    Stroke; 2013 Feb; 44(2):407-13. PubMed ID: 23287785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke.
    Kimura K; Iguchi Y; Yamashita S; Shibazaki K; Kobayashi K; Inoue T
    J Neurol Sci; 2008 Apr; 267(1-2):57-61. PubMed ID: 17964602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The association of blood pressure and collateral circulation in hyperacute ischemic stroke patients treated with intravenous thrombolysis.
    Rusanen H; Saarinen JT; Sillanpää N
    Cerebrovasc Dis; 2015; 39(2):130-7. PubMed ID: 25660943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin.
    Mazya MV; Lees KR; Markus R; Roine RO; Seet RC; Wahlgren N; Ahmed N;
    Ann Neurol; 2013 Aug; 74(2):266-74. PubMed ID: 23744571
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intraarterial recombinant tissue plasminogen activator for ischemic stroke: an accelerating dosing regimen.
    Qureshi AI; Suri MF; Shatla AA; Ringer AJ; Fessler RD; Ali Z; Guterman LR; Hopkins LN
    Neurosurgery; 2000 Aug; 47(2):473-6; discussion 477-9. PubMed ID: 10942026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
    Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M
    Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prognostic impact of time-point and degree of arterial recanalization of acute middle cerebral artery occlusions after intravenous tPA administration].
    Dorado L; Arenillas JF; Millán M; Pérez De La Ossa N; Guerrero C; Dávalos A
    Med Clin (Barc); 2009 May; 132(16):609-15. PubMed ID: 19376550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arterial status after intravenous TPA therapy for ischaemic stroke. A need for further interventions.
    Christou I; Burgin WS; Alexandrov AV; Grotta JC
    Int Angiol; 2001 Sep; 20(3):208-13. PubMed ID: 11573054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.